oral glp-1 drugs in development Four GLP-1R products Phase III trials as race intensifies Evolution of GLP‐1 Receptor Agonists

Powerful Appetite Suppression One of the main ways GLP-1 weight loss medications work is by reducing hunger and cravings

47 Education about the importance of adopting a sustainable, enjoyable, long term exercise routine for health maintenance is an integral component of a comprehensive physical therapy plan

Mller, T.D., et al

Hoffmann-La Roche AG Advanced pharmaceutical research expertise Teva Pharmaceutical Industries Ltd Global generic medicine leadership Viking Therapeutics Fast-growing obesity drug pipeline Shanghai Benemae Pharmaceutical Corporation Expanding peptide drug capabilities Biocon Limited Affordable biologics and insulin solutions Why This Market Matters: Rising global diabetes and obesity cases Increasing demand for weight management therapies Strong pharmaceutical R&D investments Growing awareness of metabolic health Expanding healthcare access across emerging economies The market is expected to create significant growth opportunities for pharmaceutical companies, investors, healthcare providers, and biotechnology innovators over the coming years

Front In Cardiovasc Med 8:742178 Patel RB, Colangelo LA, Reiner AP, Gross MD, Jacobs DR, Launer LJ, Lima JAC, Lloyd-Jones DM, Shah SJ (2020) Cellular adhesion molecules in young adulthood and cardiac function in later life